SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fauci AS 1999 The AIDS epidemic. Considerations for the 21st century. N Engl J Med 341:10461050.
  • 2
    Grinspoon SK, Bilezikian JP 1992 HIV disease and the endocrine system. N Engl J Med 327:13601365.
  • 3
    Sellmeyer DE, Grunfeld C 1996 Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 17:518532.
  • 4
    Hofbauer LC, Heufelder AE 1996 Endocrine implications of human immunodeficiency virus infection. Medicine 75:262278.
  • 5
    Wickramasinghe SN, Beatty C, Shiels S, Tomlinson DR, Harris JR 1992 Ultrastructure of the bone marrow in HIV infection: Evidence of dyshemopoiesis and stromal cell damage. Clin Lab Haematol 14:213229.
  • 6
    Sun NC, Shapshak P, Lachant NA, Hsu MY, Sieger L, Schmid P, Beall G, Imagawa DT 1989 Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies. Am J Clin Pathol 92:589594.
  • 7
    Canque B, Marandin A, Rosenzwajg M, Louache F, Vainchenker W, Gluckman JC 1995 Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 208:779783.
  • 8
    Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB 1997 Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: Demonstration by gene modification of primary human stroma. Blood 90:17871798.
  • 9
    Mellert W, Kleinschmidt A, Schmidt J, Festl H, Emler S, Roth WK, Erfle V 1990 Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS 4:527535.
  • 10
    Toneguzzi S, Lisignoli G, Monaco MC, Pozzi C, Bertollini V, Belvedere O, Degrassi A, Facchini A 1995 Osteoblastic cell lines are not susceptible to HIV-1 infection. Boll Soc Ital Biol Sper 71:275279.
  • 11
    Schratt HE, Regel G, Kiesewetter B, Tscherne H 1996 HIV-Infektion durch kältekonservierte Knochentransplantate. Unfallchirurg 99:679684.
  • 12
    Fauci AS 1996 Host factors and the pathogenesis of HIV-induced disease. Nature 384:529534.
  • 13
    Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305311.
  • 14
    Kong Y-Y, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304309.
  • 15
    Horwood NJ, Kartsogiannis V, Quinn JMW, Romas E, Martin TJ, Gillepsie MT 1999 Activated T cells support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144150.
  • 16
    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:212.
  • 17
    Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275286.
  • 18
    Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T 1999 Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247:8493.
  • 19
    Serrano S, Marinoso ML, Soriano JC, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A, Nacher M 1995 Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone 16:185191.
  • 20
    Hernandez Quero J, Ortego Centeno N, Munoz-Torres M, Martinez Perez MA, Higuera Torres-Puchol JM 1993 Alterations in bone turnover in HIV-positive patients. Infection 21:220222.
  • 21
    McNurlan MA, Garlick PJ, Frost RA, Decristofaro KA, Lang CH, Steigbigel RT, Fuhrer J, Gelato M 1998 Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: Differential effects of growth hormone administration. J Clin Endocrinol Metab 83:30503055.
  • 22
    Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Froland SS 1999 Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 84:145150.
  • 23
    Paton NIJ, Macallan DC, Griffin GE, Pazianas M 1997 Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 61:3032.
  • 24
    Stephens EA, Das R, Madge S, Barter J, Johnson MA 1999 Symptomatic osteoporosis in two young HIV-positive African women. AIDS 13:26052606.
  • 25
    Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE 2000 Accelerated bone and mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:6367.
  • 26
    Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH 1984 Autopsy findings in the acquired immune deficiency syndrome. J Am Med Assoc 252:11521159.
  • 27
    Peter SA 1992 Disorders of serum calcium in acquired immunodeficiency syndrome. J Natl Med Assoc 84:626628.
  • 28
    Hellman P, Albert J, Gidlung M, Klareskog L, Rastad J, Akerström G, Juhlin C 1994 Impaired parathyroid hormone release in human immunodeficiency virus infection. AIDS Res Hum Retroviruses 10:391394.
  • 29
    Jaeger P, Otto S, Speck RF, Villiger L, Horber FF, Casez JP, Takkinen R 1994 Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 79:17011705.
  • 30
    Zaloga GP, Chernow B 1987 The multifactorial basis for hypocalcemia during sepsis: Studies of parathyroid hormone-vitamin D axis. Ann Intern Med 107:3641.
  • 31
    Hellman P, Karlsson-Parra A, Klareskog L, Ridefelt P, Bjerneroth G, Rastad J, Akerstrom G, Juhlin C 1996 Expression and function of a CD4-like molecule in parathyroid tissue. Surgery 120:985992.
  • 32
    Lehmann R, Leuzinger B, Salomon F 1994 Symptomatic hypoparathyroidism in acquired immunodeficiency syndrome. Horm Res 42:295299.
  • 33
    St John A, Hoag K, Mallon D, French M 1995 Serum parathyroid hormone concentrations in patients with HIV infection. Ann Clin Biochem 32:9495.
  • 34
    Kuehn EW, Anders HJ, Bogner JR, Obermaier J, Goebel FD, Schlöndorff D 1999 Hypocalcaemia in HIV infection and AIDS. J Intern Med 245:6973.
  • 35
    Zaloga GP, Chernow B, Eil C 1985 Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med 102:331333.
  • 36
    Fallatah S, Halim MA, Ellis ME 1995 Hypercalcemia associated with cytomegalovirus infection in the acquired immunodeficiency virus syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 8:101102.
  • 37
    Ahmed B, Jaspan JB 1993 Hypercalcemia in a patient with AIDS and Pneumocystis carinii pneumonia. Am J Med Sci 306:313316.
  • 38
    Delahunt JW, Romeril KE 1994 Hypercalcemia in a patient with the acquired immuno-deficiency syndrome and Mycobacterium avium intracellulare infection. J Acquir Immune Defic Syndr 7:871872.
  • 39
    Aly ES, Baig M, Khanna D, Baumann MA 1999 Hypercalcemia: A clue to Mycobacterium avium intracellular infection in a patient with AIDS. Int J Clin Pract 53:227228.
  • 40
    Spindel SJ, Hamill RJ, Georghiou PR, Lacke CE, Green LK, Mallette LE 1995 Vitamin D-mediated hypercalcemia in fungal infection. Am J Med Sci 310:7176.
  • 41
    Ali MY, Gopal KV, Llerena LA, Taylor HC 1999 Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis. Am J Med Sci 318:419423.
  • 42
    Carbone LD, Land MA, Stentz FB, Palmieri GM 1995 Elevated cytokine levels in a patient with AIDS and hypercalcemia: Effects of therapy with pamidronate. Clin Infect Dis 21:699.
  • 43
    Al-Tawfiq JA, Cushing HE 1999 Hypercalcemia as an early sign of lymphoma in a patient with acquired immunodeficiency syndrome (AIDS). South Med J 92:924926.
  • 44
    Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR 1989 Vitamin D metabolite-mediated hypercalcemia and hypercalciuria in patients with AIDS- and non-AIDS-associated lymphoma. Blood 73:235239.
  • 45
    Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB 1996 Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 125:873882.
  • 46
    Bruns ME, Vollmer SS, Bruns DE, Overpeck JG 1983 Human growth hormone increases intestinal vitamin D-dependent calcium-binding protein in hypophysectomized rats. Endocrinology 113:13871392.
  • 47
    Lancer SR, Bowser EN, Hargis GK 1976 The effect of growth hormone on parathyroid function in rats. Endocrinology 98:12891293.
  • 48
    Sakoulas G, Tritos NA, Lally M, Wanke C, Hartzband P 1997 Hypercalcemia in an AIDS patient treated with growth hormone. AIDS 11:13531356.
  • 49
    Gayet S, Ville E, Durand JM, Mars ME, Morange S, Kaplanski G, Gallais H, Soubeyrand J 1997 Foscarnet-induced hypercalcemia in AIDS. AIDS 11:10681070.
  • 50
    Perazella MA, Brown E 1994 Electrolyte and acid-base disorders associated with AIDS: An etiologic review. J Gen Intern Med 9:232236.
  • 51
    Youle MS 1988 Severe hypocalcemia in AIDS patients treated with foscarnet and pentamidine. Lancet 331:14551456.
  • 52
    Palestine AG, Polis MA, De Smet MD, Baird BF, Falloon J, Kovacs JA, Davey RT, Zurlo JJ, Zunich KM, Davis M, Hubbard L, Brothers R, Ferris FL, Chew E, Davis JL, Rubin BI, Mellow SD, Metcalf JA, Manischewitz J, Minor JR, Nussenblatt RB, Masur H, Lane HC 1991 A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 115:665673.
  • 53
    Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA 1991 Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 72:11301135.
  • 54
    Shah GM, Alvarado P, Kirschenbaum MA 1990 Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med 89:380382.
  • 55
    Wharton JM, Coleman DL, Wofsy CB, Luce JM, Blumenfeld W, Hadley WK, Ingram-Drake L, Volberding PA, Hopewell PC 1986 Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med 105:3744.
  • 56
    Haug C, Müller F, Aukrust P, Froland SS 1994 Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with degree of immune deficiency and survival. J Infect Dis 169:889893.
  • 57
    Haug C, Aukrust P, Lien E, Müller F, Espevik T, Froland SS 1996 Disseminated Mycobacterium avium complex infection in AIDS: Immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25-dihydroxyvitamin D. J Infect Dis 173:259262.
  • 58
    Haug CJ, Aukrust P, Haug E, Morkrid L, Müller F, Froland SS 1998 Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 83:38323898.
  • 59
    Aukrust P, Liabakk NB, Müller F, Lien E, Espevik T, Froland SS 1994 Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection—correlations to clinical, immunologic, and virologic parameters. J Infect Dis 169:420424.
  • 60
    Coodley GO, Loveless MO, Nelson HD, Coodley MK 1994 Endocrine function in the HIV wasting syndrome. J Acquir Immune Defic Syndr 7:4651.
  • 61
    Mayur N, Lewis S, Catherwood BD, Nanes MS 1993 Tumor necrosis factor α decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells. J Bone Miner Res 8:9971003.
  • 62
    Tsoukas CD, Provvedine DM, Manolagas SC 1984 1,25-Dihydroxyvitamin D3, a novel immunoregulatory hormone. Science 221:14381440.
  • 63
    Pauza CD, Kornbluth R, Emau P, Richman DD, Deftos LJ 1988 Human immunodeficiency virus infection of monoblastoid cells: Cellular differentiation determines the pattern of virus replication. J Virol 62:35583564.
  • 64
    Locardi C, Petrini C, Boccoli G, Testa U, Dieffenbach C, Butto S, Belardelli F 1990 Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: Roles of interferon and tumor necrosis factor in regulation of HIV production. J Virol 64:58745882.
  • 65
    Skolnik PR, Jahn B, Wang MZ, Rota TR, Hirsch MS, Krane SM 1991 Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxy-cholecalciferol. Proc Natl Acad Sci USA 88:66326636.
  • 66
    Connor RI, Rigby WF 1991 1α,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun 176:852859.
  • 67
    Schuitemaker H, Koostra NA, Koppelman MH, Bruisten SM, Huisman HG, Tersmette M, Miedema F 1992 Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 89:11541160.
  • 68
    Goletti D, Kinter AL, Biswas P, Bende SM, Poli G, Fauci AS 1995 Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: Dissociation of cellular differentiation and viral expression. J Virol 69:25402546.
  • 69
    Biswas P, Mengozzi M, Mantelli B, Delfanti F, Brambilla A, Vicenzi E, Poli G 1998 1,25-dihydroxyvitamin D3 up-regulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-κB-independent enhancement of viral replication. J Virol 72:83808383.
  • 70
    Abu-Amer Y, Bar-Shavit Z 1994 Regulation of TNF-α release from bone marrow-derived macrophages by vitamin D. J Cell Biochem 55:435444.
  • 71
    Steinbach LS, Tehranzadeh J, Fleckenstein JL, Vanarthos WJ, Pais MJ 1993 Human immunodeficiency virus infection: Musculoskeletal manifestations. Radiology 186:833838.
  • 72
    Friedman-Kien AE, Saltzman BR 1990 Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 22:12371250.
  • 73
    Isenbarger DW, Aronson NE 1994 Lytic vertebral lesions: An unusual manifestation of AIDS-associated Kaposi's sarcoma. Clin Infect Dis 19:751755.
  • 74
    Langford A, Pohle HD, Reichart P 1991 Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement. Int J Oral Maxillofac Surg 20:366368.
  • 75
    Meyers SA, Kuhlman JE, Fishman EK 1990 Kaposi sarcoma involving bone: CT demonstration in a patient with AIDS. J Comput Assist Tomogr 14:161162.
  • 76
    Turner L, Saveuse H, Rouveix E 1997 Lytic vertebral lesions in a patient with AIDS: A new case of Kaposi's sarcoma involving bones. J Rheumatol 24:20542055.
  • 77
    Teh BS, Lu HH, Lynch GR, Banez E, Kroll MH 1999 AIDS-related Kaposi's sarcoma involving bone and bone marrow. South Med J 92:6164.
  • 78
    Piira TA, Ries K, Kjeldsberg CR, Perkins SL 1994 Anaplastic large-cell lymphoma presenting primarily in bone in a patient with AIDS. Hematol Pathol 8:111116.
  • 79
    Song YG, Hahn JS, Choi YH, Yeom JS, Yang WI, Seo CO, Kim JM 1998 A case of primary bone lymphoma associated with acquired immunodeficiency syndrome. Yonsei Med J 39:383389.
  • 80
    Castanet J, Lacour JP, Taillan B, Perrin C, Garnier G, Ortonne JP 1997 Two cases of localized B-cell lymphoma in the acquired immunodeficiency syndrome. Dermatology 194:185187.
  • 81
    Aboulafia AJ, Khan F, Pankowsky D, Aboulafia DM 1998 AIDS-associated secondary lymphoma of bone: A case report with review of the literature. Am J Orthop 27:128134.
  • 82
    List AF 1988 Metastatic giant-cell bone tumor in a man positive for HIV. N Engl J Med 318:517.
  • 83
    Karnad AB, Martin AW, Koh HK, Brauer MJ, Novich M, Wright J 1989 Nonsecretory multiple myeloma in a 26-year-old man with acquired immunodeficiency syndrome, presenting with multiple extramedullary plasmacytomas and osteolytic bone disease. Am J Hematol 32:305310.
  • 84
    Conrad SE, Jacobs D, Gee J, Fernandez A, Baciocco EA 1991 Pseudoneoplastic infection of bone in acquired immunodeficiency syndrome. A case report involving the cat-scratch disease bacillus. J Bone Joint Surg (Am) 73:774777.
  • 85
    Baron AL, Steinbach LS, LeBoit PE, Mills CM, Gee JH, Berger TG 1990 Osteolytic lesions and bacillary angiomatosis in HIV infection: Radiologic differentiation from AIDS-related Kaposi sarcoma. Radiology 177:7781.
  • 86
    Olive A, Tena X, Raventos A, Romeu J, Lorenzo JC, Ojanguren I, Perez R 1996 Bone bacillary angiomatosis in an HIV-infected patient. Br J Rheumatol 35:901904.
  • 87
    Gomez-Jorge JT, Donahue F, Ganz W, Poblete RB, Rodriguez MM 1996 Osseous manifestations of bacillary angiomatosis. Skeletal Radiol 25:505508.
  • 88
    Lefkowitz RA, Singson RD 1998 Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions. Skeletal Radiol 27:334336.
  • 89
    Lyos AT, Malpica A, Estrada R, Katz CD, Jenkins HA 1993 Invasive aspergillosis of the temporal bone: An unusual manifestation of acquired immunodeficiency syndrome. Am J Otolaryngol 14:444448.
  • 90
    Kastner RJ, Malone JL, Decker CF 1994 Syphilitic osteitis in a patient with secondary syphilis and concurrent human immunodeficiency virus infection. Clin Infect Dis 18:250252.
  • 91
    Selby DM, Chandra RS, Rakusan TA, Loechelt B, Markle BM, Visvesvara GS 1998 Amebic osteomyelitis in a child with acquired immunodeficiency syndrome: A case report. Pediatr Pathol Lab Med 18:8995.
  • 92
    Orwoll ES, Klein RF 1995 Osteoporosis in men. Endocr Rev 16:87116.
  • 93
    Horowitz MC 1993 Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626627.
  • 94
    Riggs BL, Khosla S, Melton LJ 1998 A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763773.
  • 95
    Dobs AS, Dempsey MA, Ladenson PW, Polk BF 1988 Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 84:611616.
  • 96
    Croxson TS, Chapman WE, Miller LK, Levit CD, Senie R, Zumoff B 1989 Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 68:317321.
  • 97
    Raffi F, Brisseau JM, Planchon B, Remi JP, Barrier JH, Grolleau JY 1991 Endocrine function in 98 HIV-infected patients: A prospective study. AIDS 5:129133.
  • 98
    Wagner G, Rabkin JG, Rabkin R 1995 Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness. J Acquir Immune Defic Syndr Hum Retrovirol 8:204207.
  • 99
    Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez EA 1992 Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 5:841846.
  • 100
    Honour JW, Schneider MA, Miller RF 1995 Low adrenal androgens in men with HIV infection and the acquired immunodeficiency syndrome. Horm Res 44:3539.
  • 101
    Mulder JW, Frissen PHJ, Krijnen P, Endert E, de Wolf F, Goudsmit J, Masterson JG 1992 Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165:41134118.
  • 102
    Wisniewski TL, Hilton CW, Morse EV, Svec F 1993 The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305:7983.